The FDA has approved a new daily HIV pill from Gilead, aimed at simplifying treatment for some patients who are doing well on existing regimens like Biktarvy. It allows them to switch to a new treatment without the need for multiple pills.
מקור: Business News — לכתבה המלאה
כתיבת תגובה